Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China · Delayed Price · Currency is CNY 33.83
-0.81 (-2.34%)
Apr 9, 2026, 3:00 PM CST
SHA:600976 Revenue
In the year 2025, Jianmin Pharmaceutical Group had annual revenue of 3.37B CNY, down -3.85%. Jianmin Pharmaceutical Group had revenue of 817.97M in the quarter ending December 31, 2025, with 31.16% growth.
Revenue
3.37B
Revenue Growth
-3.85%
P/S Ratio
1.58
Revenue / Employee
1.49M
Employees
2,257
Market Cap
5.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.37B | -135.08M | -3.85% |
| Dec 31, 2024 | 3.50B | -708.17M | -16.81% |
| Dec 31, 2023 | 4.21B | 572.35M | 15.72% |
| Dec 31, 2022 | 3.64B | 341.37M | 10.35% |
| Dec 31, 2021 | 3.30B | 843.43M | 34.34% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.63B |
| Luoxin Pharmaceuticals Group Stock | 2.49B |
| Bide Pharmatech | 1.32B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Beijing Beilu Pharmaceutical | 1.13B |
| Teyi Pharmaceutical Group Co.,Ltd | 924.53M |
| ChengDu ShengNuo Biotec | 741.34M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 619.88M |